Spelling suggestions: "subject:"raphe"" "subject:"aphe""
51 |
Organização das projeções do córtex pré-fontral para o núcleo dorsal da rafe no rato. / Organization of the projections from the prefrontal cortex to the dorsal raphe nucleus in the rat.Luciano Gonçalves 18 August 2008 (has links)
O núcleo dorsal da rafe (DR) envia densas projeções para o prosencéfalo e está implicado em várias funções complexas. Muitos estudos indicam que a atividade neuronal do DR é controlada por neurônios do córtex pré-frontal (PFC). Devido à escassez de informações detalhadas sobre as conexões entre o PFC e o DR, objetivamos mapear sistematicamente as projeções do PFC para o DR. O traçador neuronal toxina colérica subunidade b (CTb) foi injetado nas diferentes partes do DR. Com técnica imunoistoquímica contra a CTb, células CTb-ir foram encontradas em maior escala no córtex polar frontal e na parede medial do PFC. No PFC lateral, o córtex da insula agranular dorsal, apresentou maior densidade de neurônios CTb-ir. No PFC orbital, o córtex orbital lateral e dorso-lateral eferentam principalmente a parte central do DR. Injeções situadas na parte caudal do DR resultaram em marcação atenuada. Os resultados indicam que o PFC envia robustas projeções para o DR de forma diferenciada. Através dessas projeções o PFC pode exercer um controle \"top down\" sobre os neurônios do DR. / The dorsal raphe nucleus (DR) sends massive projections to the forebrain and is implicated in a variety of complex functions. Several studies indicate that neuronal activity in the DR is controlled by the prefrontal cortex (PFC). Since there is no detailed information about the projections from the PFC to the DR, the goal of the present study was to map these projections systematically. The neuronal tracer cholera toxin, subunit b (CTb) was injected at different levels of the DR. By immunohistochemical methods, CTb-ir cells were found highly enriched in the frontal polar cortex and in the medial wall of the PFC. In the lateral PFC, the dorsal lateral insular cortex presented the highest density of CTb-ir neurons. In the orbital PFC, the lateral and dorso-lateral orbital cortex project principally to the central segment of the DR. Injections in the caudal segment of the DR resulted in reduced CTb staining. Our results indicate that the PFC sends massive topographically organized projections to the DR, which may exert a \"top down\" control over neurons in the DR.
|
52 |
Mediação do medo condicionado contextual por mecanismos serotoninérgicos do circuito núcleo mediano da rafe-hipocampo dorsal / Serotonergic mechanisms of the median raphe nucleusdorsal hippocampus in conditioned fear: Output circuit involves the prefrontal cortex and amygdalaRafael Carvalho Almada 18 May 2009 (has links)
Vários estudos mostram que o núcleo mediano da rafe (NMR) e o hipocampo dorsal (HD) estão envolvidos no medo condicionado Pavloviano. Além disso, mecanismos serotoninérgicos do NMR parecem participar da expressão da resposta de medo condicionado contextual. Entretanto, ainda não existe uma abordagem experimental que integre os mecanismos do circuito NMR-HD. Neste trabalho, o paradigma do medo condicionado foi utilizado para testar a influência dos mecanismos serotoninérgicos do circuito NMR-HD no medo condicionado contextual. As respostas de sobressalto e congelamento foram avaliadas após a administração de drogas serotoninérgicas intra-NMR e no HD, 6 h depois a sessões treino, nas quais os ratos eram condicionados com choques nas patas. A redução da transmissão serotoninérgica no NMR é devido a microinjeção do 8-hidroxi-2(di-n-propilamino)-tetralin (8-OH-DPAT), um agonista de receptores 5-HT1A, no NMR promoveu redução das respostas de congelamento, mas não alterou a resposta de sobressalto. Estes resultados são consistentes com a ideia de que mecanismos serotoninérgicos no NMR regulam as respostas de congelamento a um contexto aversivo. A diminuição pós-sináptica da serotonina nas áreas de projeção do NMR ocorre devido a ativação de autoreceptores 5-HT1A nesta estrutura. Com relação ao hipocampo, a microinjeção de cetanserina, um antagonista de receptores 5-HT2, não promoveu alteração nas respostas de congelamento e sobressalto potencializado pelo medo, porém a ativação de receptores 5-HT1A pela injeção de 8-OH-DPAT 6 h após o treino inibiu essas respostas. De acordo com esses resultados, um mecanismo inibitório deva se interpor entre os processos associados à chegada de informação aversiva e os associados à saída delas no HD. As projeções HD-amígdala e córtex pré-frontal medial podem constituir a porta de saída dos processos neurais subjacentes a expressão do medo condicionado contextual, conforme foi observado no experimento em que estudou a imunorreatividade destas estruturas á proteína Fos em ratos submetidos ao mesmo procedimento experimental de medo condicionado contextual / Several studies have shown that the median raphe nucleus (MRN) and dorsal hippocampus (DH) are involved in Pavlovian conditioned fear. Moreover, previous findings have also implicated serotonergic mechanisms of the MRN in the retrieval of contextual conditioned fear. However, studies that examine the integrated involvement of serotonergic mechanisms of the MRN-DH are lacking. This study, a fear conditioning paradigm was used to test whether the serotonergic projections from the MRN to DH can influence contextual fear conditioning. Startle and freezing responses were avaliated after administration of serotoninergics drugs into the MRN or DH, 6 h previously rats received footshocks in the training session. A reduction of 5-HT transmission in the MRN by local infusions of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH-DPAT) decreased freezing in response to the CS but did not reduce fear-potentiated startle. This pattern of results is consistent with the hypothesis that MRN serotonergic mechanisms selectively modulate the freezing response to the aversive context. As for the DH, a decrease in postsynaptic 5-HT receptor activity at projection areas has been proposed to be the main consequence of 5-HT1A receptor activation in the MRN. Infusions of the 5-HT2 receptor antagonist ketanserin into the DH had no effect, but activation of 5-HT1A receptors through intra-DH injections of 8-OH-DPAT inhibited both the freezing and fear-potentiated startle response to the CS. To reconcile these findings, an inhibitory mechanism may exist between the incoming DH 5-HT pathway from the MRN and the presynaptic 5-HT neurons that are part of the DH output to other structures. The DH-amygdala and medial prefrontal cortex projections could well be this output circuit modulating the expression of contextual fear conditioning as revealed by measurements of Fos immunoreactivity in these areas.
|
53 |
Papel da via Núcleo Mediano da Rafe-Hipocampo Dorsal nos efeitos antidepressivos do tratamento com Imipramina / Role of Median Raphe Nucleus- Dorsal Hippocampus pathway in the antidepressant effects of treatment with imipramine.Kelly da Silva 31 March 2011 (has links)
Introdução: A depressão é um transtorno psiquiátrico cujas causas parecem envolver a exposição crônica a estressores. Sabe-se que o hipocampo dorsal (HD) tem participação no mecanismo de adaptação a estímulos aversivos contínuos, pois a facilitação da neurotransmissão serotonérgica nessa estrutura diminui o efeito de um estressor prévio. A principal fonte de inervação serotonérgica para o HD é o núcleo mediano da rafe (NMnR). Objetivo: O objetivo geral deste trabalho foi verificar se a integridade da via NMnR-HD é essencial para os efeitos antidepressivos do tratamento crônico com Imipramina em animas com lesão dos neurônios serotonérgicos do NMnR e submetidos ao estresse crônico repetido. Materias e Métodos: Foram utilizados ratos Wistar, machos, com sete semanas de vida. Estes animais foram submetidos à cirurgia estereotáxica para lesão (ou não - grupo controle) dos neurônios seronotérgicos do NMnR. Novamente foram subdivididos em grupos de acordo com o tratamento farmacológico que iriam receber cronicamente (Imipramina ou Salina). Todos os animais foram submetidos ao estresse de restrição crônico (7dias/duas horas por dia) ou agudo (episódio único de restrição. No oitavo dia os animais foram testados no Labirinto em cruz Elevado (LCE). Resultados: Quando submetidos ao estresse agudo, animais com o NMnR íntegro e tratados com Imipramina apresentaram uma maior porcentagem de tempo despendido nos braços abertos (%TA) e no número de entradas nos braços abertos (%FA), quando comparados com o controle. Ainda, quando submetidos ao estresse agudo e com NMnR lesionados quimicamente, observou-se uma maior exploração dos braços abertos (%TA e %FA) quando comparados com o grupo sem lesão. Em relação aos animais submetidos ao estresse crônico, tanto os animais com NMnR íntegro, quanto os com este núcleo lesionados, a Imipramina foi capaz de atenuar os efeitos do estresse, pois foi observado uma maior %TA e %FA quando comparados com os animais que receberam salina. A lesão do NMnR em animais submetidos ao estresse crônico e tratados com salina apresentaram uma diminuição tanto da %TA quanto da %FA, quando comparados com as animais tratados com salina e com NMnR íntegro. Discussão: Nossos resultados mostraram que a lesão dos neurônios serotonérgicos do NMnR não interferiu no comportamento dos animais no LCE quando submetidos a um episódio único de estresse, mas diminui a exploração dos braços abertos em animais submetidos ao estresse crônico. Este efeito, contudo, foi atenuado pela administração crônica de Imipramina. Conclusão: Estes resultados sugerem que a integridade da via NMnR-HD não é essencial para os efeitos antidepressivos da Imipramina no desenvolvimento da tolerância ao estresse repetido. / Introduction: Depression is a psychiatric disorder whose causes seem to involve chronic exposure to stressors. It is known that the dorsal hippocampus (DH) participates in the adaptation mechanism to aversive stimuli, once the facilitation of serotonergic neurotransmission in this structure reduces the effect of a stressor. The main source of serotonergic innervation to the HD is the median raphe nucleus (MRN). Aim: The aim of this study was to verify if the integrity of the MRN-HD pathway is essential for the antidepressant effects of chronic treatment with imipramine in animals with lesion on serotonergic neurons of MRN submitted to chronic and repeated stress. Materials and Methods: We used male Wistar rats, seven weeks old. The animals were submitted to stereotactic surgery for lesion (or not - control group) on MRN serotonergic neurons. Later, they were divided in groups according to the chronic drug treatment they would receive (Imipramine or Saline). All animals were subjected to chronic (7days/Two hours a day) or acute restraint stress (a single episode of restraint). On the eighth day the animals were tested in the Elevated Plus Maze (EPM). Results: When subjected to acute stress, animals with intact MRN and treated with imipramine showed a higher percentage of time spent in open arms (% TO) and the number of entries in open arms (% FO) when compared to control. Moreover, rats subjected to acute stress and chemically injured showed a greater exploration of open arms (% TO and % FO) when compared with the group without lesion. Imipramine was able to attenuate the effects of stress on animals subjected to chronic stress from both groups, with intact MRN and those with lesion. That was observed on a increase of % TO and % FO when compared with rats treated with saline. The injury on MNR in animals submitted to chronic stress decreased both %TO and % FO. Discussion: Our results showed that the lesion on serotonergic neurons of MNR dont interfere in the behavior of animals in the EPM when subjected to a single stress episode, but decreases the open arm exploration in rats exposed to chronic stress. This effect, however, was attenuated by chronic administration of imipramine. Conclusion: These results suggest that the integrity of the NMnR-HD pathway is not essential for the antidepressant effects Imipramine in the development of tolerance to repeated stress.
|
54 |
Rôle du récepteur sérotoninergique de type 4 dans le traitement rapide et prophylactique de l’anxiété : implication du circuit cortex-raphé / Role of serotonin type 4 receptor in rapid and prophylactic treatment of anxiety : involvement of the cortex-brainstem neural circuit.Faye, Charlène 27 March 2019 (has links)
Résumé : les benzodiazépines (BZD) et les antidépresseurs sont efficaces pour réduire l’anxiété, mais devant les effets indésirables que les BZD induisent et face au délai d’action des antidépresseurs, le développement de nouvelles stratégies constitue un besoin primordial. Récemment, il a été montré que l’activation du récepteur 5-HT4 (5-HT4R) pouvait représenter une cible d’action prometteuse. Bien qu’un certain nombre d’études ait évalué l’activité anxiolytique des agonistes du 5-HT4R, après une administration chronique, aucune étude n’a examiné leurs effets après une administration unique, ni même le circuit cérébral à la base de cette réponse comportementale. Nous avons donc cherché à savoir si l’activation aiguë du 5-HT4R via le recrutement des terminaisons neuronales glutamatergiques du cortex préfrontal médian (CPFm) se projetant sur le noyau du raphé dorsal (NRD), un circuit impliqué dans les processus émotionnels, induisait des effets anxiolytiques rapides, grâce à des outils pharmacologiques, électrophysiologiques et optogénétiques. L’administration unique par voie systémique ou intra-CPFm d’un agoniste du 5-HT4R a produit des effets anxiolytiques rapides chez la souris, associés à une augmentation de l’activité des neurones sérotoninergiques du NRD. L’activation des projections glutamatergiques du CPFm vers le NRD a permis de réduire l’anxiété des souris, alors que l’inhibition de ces projections a bloqué les effets anxiolytiques induits par l’injection unique intra-CPFm d’une BZD (diazépam) ou d’un agoniste du 5-HT4R (RS 67333). Toutefois, ces effets ne sont que partiellement bloqués après l’administration par voie systémique de ces composés, suggérant que le circuit cortex-raphé est un carrefour nécessaire mais non suffisant à l’activité anxiolytique du diazépam et du RS 67333. Enfin, l’administration prophylactique d’un agoniste du 5-HT4R avant l’induction d’un stress a prévenu le développement d’un phénotype anxio-dépressif chez la souris, laissant penser que cette molécule pourrait renforcer la résilience au stress des populations à risque. / Benzodiazepines (BZD) and antidepressants are effective in reducing anxiety, but adverse effects of BZD and the delayed onset of action of antidepressants emphasize the need to develop fast-acting new drugs. Recent studies indicated that activation of 5-HT4 receptor (5-HT4R) could be a promising target. Although a number of studies have assessed 5-HT4R agonist anxiolytic activity after chronic treatment, few of them have neither evaluated their anxiolytic profile acutely, neither the brain circuits involved in this behavioral activity. Here, we evaluated whether acute 5-HT4R activation in glutamatergic axon terminals arising from the medial prefrontal cortex (mPFC) to the dorsal raphe nucleus (DRN), a circuit involved in emotional processes, induced fast anxiolytic effects, using pharmacologic, electrophysiologic and optogenetic tools. Acute systemic administration and intra-mPFC infusion of 5-HT4R produced fast anxiolytic effects in mice and increased DRN serotonin cell firing. Optogenetically activating mPFC terminals targeting the DRN reduced anxiety in mice whereas silencing this circuit blocked BZD (diazepam) and 5-HT4R agonist (RS 67333) mPFC infusion -induced anxiolytic effects. However, anxiolytic effects induced by an acute systemic administration of both molecules were partially blocked after optogenetically inhibiting cortical glutamatergic terminals in the DRN, suggesting that cortex-brainstem neural circuit is necessary but not sufficient for a rapid activity of diazepam and RS 67333. Finally, the prophylactic administration of a 5-HT4R agonist before stress prevented the development of an anxio-depressive phenotype in mice, suggesting that this molecule could reinforce the resilience of population at risk.
|
55 |
Estrogen Receptor-Beta Dependent Activities of Dietary Compounds in a Genetically Modified Rat Raphe Nuclei-Derived Cell LineAmer, Dena Ahmed Mohamed 10 June 2011 (has links)
Estrogens greatly affect the activity and connectivity of serotonergic neural cell populations, which extend from clusters of nuclei in the brainstem, termed the raphe nuclei, where estrogen receptor β is the most abundantly expressed estrogen receptor subtype. Estrogenic effects on the raphe nuclei are primarily important for influencing various neuropsychological behaviors, including depression, mood swings and anxiety behaviors. Because of this connection, phases of intense hormone fluctuations for instance during menopause are often associated with several mood disturbances that often reduce the quality of life of menopausal women. Accordingly, long-term use of hormone replacement therapy appeared to be the method of choice for many menopausal women to help alleviate vasomotor symptoms, which may include neuropsychological changes such as depression. However, given the limitations and number of serious health risks attributed to hormone replacement therapy, natural compounds such as phytoestrogens are receiving widespread awareness due to their occurrence in medicinal plant extracts and a wide variety of food items including dietary supplements with respective health claims. Flavonoids, particularly the isoflavones and the naringenin-type flavanones, belong to a group of polyphenolic plant-derived secondary metabolites known to possess estrogen-like bioactivities. Nevertheless, little is known about their transactivational activity and their potential to regulate endogenous gene expression of estrogen responsive genes in the raphe nuclei due to the lack of suitable cellular models expressing sufficient amounts of functional estrogen receptor β.
Hence, a raphe nuclei-derived cell line that expresses a functional estrogen receptor β was sought as a model to investigate effects of flavonoids in vitro. In this regard, RN46A-B14 cells derived from embryonic day 13 rat medullary raphe nuclei were primarily used in this study as the main cellular model. Nonetheless, expression of endogenous estrogen receptor β in these cells was not sufficient to pursue downstream investigations of estrogen-dependent activities. To overcome this deficit, a rat raphe nuclei-derived in vitro model that overexpresses a functional estrogen receptor β was initially established (herein termed RNDA cells) by stably transducing its parent cell line, RN46A-B14 cells, with a suitable lentiviral expression vector encoding a human estrogen receptor β gene. The stable expression and the functional characterization of the transgenic receptor was confirmed by Western blot analysis and luciferase reporter gene assays, respectively. The same reporter gene assay was used to scrutinize the transactivational activity of the flavonoids in RNDA cells. Key results revealed that Genistein, Daidzein, Equol, Naringenin and 8-Prenylnaringenin demonstrated high transactivational activity in a concentration-dependent manner by stimulating luciferase expression from an estrogen responsive element-regulated reporter gene construct transiently transfected in RNDA cells. Low transactivational activity was observed in RNDA cells in response to increasing concentrations of 7-(O-prenyl)naringenin-4'-acetate. However, no transactivational activity was noticed in response to 6-(1,1-Dimethylallyl)naringenin in the studied cell model. All effects elicited by the flavonoids were antagonized by the pure estrogen receptor antagonist, Fulvestrant, indicating that all substances act by binding to and activating the transgenic ERβ. Additional effects were observed in RNDA cells in response to a co-treatment of 1 µM of either Genistein or Daidzein, but not Equol, with 10 nM 17β-Estradiol. Slight antagonistic effects were observed in the same studied cell line when either 8-Prenylnaringenin or 7-(O-prenyl)naringenin-4'-acetate, but not Naringenin or 6-(1,1-Dimethylallyl)naringenin, were co-added with 17β-Estradiol.
Results from the reporter gene assays were validated on the basis of regulation of mRNA expression of estrogen responsive genes following the global assessment of 17β-Estradiol-induced gene expression in this cell line using a DNA microarray technique. Out of 212 estrogen-regulated genes with at least two-fold change of expression, six were selected according to specific features of estrogenic regulation of expression. The expression of the six selected 17β-Estradiol-regulated genes was validated using quantitative real-time PCR analysis. The regulation of mRNA expression of the selected genes in response to the tested flavonoids was then investigated in RNDA cells. Additionally, because RNDA cells encode a temperature-sensitive mutant of the Simian Virus 40 large T-antigen, their neuronal differentiation is constitutive upon shifting them from conditions promoting proliferation (permissive temperature) to differentiation (non permissive temperature). Hence, the regulation of mRNA expression of the selected genes in response to the tested flavonoids was additionally investigated as RNDA cells differentiate.
In RNDA cells grown under proliferative conditions, 17β-Estradiol up-regulated mRNA expression of camello-like 5, sex determining region Y-box 18 and keratin type I cytoskeletal 19. Similar effects were observed in response to 8-Prenylnaringenin, Genistein, Daidzein and Equol. In addition, 17β-Estradiol down-regulated mRNA expression of neurofilament medium polypeptide and zinc finger DHHC-type containing 2. Similar effects were observed in response to 8-Prenylnaringenin, Naringenin, Genistein, Daidzein and Equol. Yet, no effect was observed on the regulation of mRNA expression of solute carrier family 6 member 4 in response to 17β-Estradiol or the flavonoids in RNDA cells grown under proliferative conditions. When RNDA cells were shifted to conditions promoting differentiation, changes in cell morphology, in mRNA expression levels and in responsiveness towards 17β-Estradiol or the flavonoids were observed. These expression studies additionally highlighted some of the genes as indicator genes for RNDA cellular differentiation.
The newly established RNDA cell line should prove useful to elucidate basic physiological properties of estrogen receptor β in the raphe nuclei. The present study should serve as the basis to help shed light on molecular and cellular mechanisms following the action of phytoestrogens, endocrine disruptors or other exogenous estrogen receptor ligands in neural cell populations, particularly the raphe nuclei, for further applications within the brain.
|
56 |
METABOLIC ACIDOSIS AND THE DIVERSE ROLES OF THE Cl/HCO<sub>3</sub> EXCHANGER (AE3) IN INTRACELLULAR pH HOMEOSTASISSalameh, Ahlam Ibrahim January 2016 (has links)
No description available.
|
57 |
Substance P, récepteurs NK1 et neurones à sérotonine : relations anatomiques et fonctionnelles dans le noyau raphe dorsalisBaptiste, Lacoste 06 1900 (has links)
Nous avons étudié les relations anatomiques entre les systèmes de neurotransmission à substance P (SP) et à sérotonine (5-hydroxytryptamine, 5-HT) dans le noyau du raphé dorsal (NRD) du rongeur, afin de mieux comprendre les interactions entre ces systèmes durant la régulation de l’humeur.
Le NRD reçoit une innervation SP provenant de l’habenula, et le blocage pharmacologique des récepteurs neurokinine-1 (rNK1) de la SP aurait des effets antidépresseurs. Chez le rongeur, le traitement par les antagonistes des rNK1 s’accompagne d’une désensibilisation des autorécepteurs 5-HT1A de la 5-HT et d’une hausse de l’activité des neurones 5-HT dans le NRD, suggérant des interactions locales entre ces deux systèmes.
Dans un premier temps, nous avons démontré par doubles marquages immunocytochimiques en microscopies optique, confocale et électronique, la présence du rNK1 dans une sous-population de neurones 5-HT du NRD caudal. Lors de l’analyse en microscopie électronique, nous avons pu constater que les rNK1 étaient principalement cytoplasmiques dans les neurones 5-HT et membranaires sur les neurones non 5-HT du noyau. Grâce à d’autres doubles marquages, nous avons aussi pu identifier les neurones non-5-HT porteurs de rNK1 comme étant GABAergiques.
Nous avons ensuite combiné l’immunomarquage de la SP avec celui du rNK1, dans le but d’examiner les relations entre les terminaisons (varicosités *) axonales SP et les neurones 5-HT (pourvus de rNK1 cytoplasmiques du NRD caudal. En simple marquage de la SP, nous avons pu estimer à 41% la fréquence avec laquelle les terminaisons SP font synapse. Dans le matériel doublement marqué pour la SP et son récepteur, les terminaisons SP ont été fréquemment retrouvées en contact direct ou à proximité des dendrites munies de rNK1 cytoplasmiques, mais toujours éloignées des dendrites à rNK1 membranaires. Pour tester l’hypothèse d’une internalisation soutenue des rNK1 par la SP dans les neurones 5-HT, nous avons ensuite examiné la localisation subcellulaire du récepteur chez le rat traité avec un antagoniste du rNK1, le RP67580. La densité du marquage des rNK1 a été mesurée dans le cytoplasme et sur la membrane des deux types de dendrites (5-HT: rNK1 cytoplasmiques; non 5-HT: rNK1 membranaires). Une heure après une injection unique de l’antagoniste, la distribution du rNK1 est apparue inchangée dans les deux types de neurones (5-HT et non 5-HT). Par contre, après un traitement quotidien de 7 ou 21 jours avec l’antagoniste, nous avons mesuré une augmentation significative des densités cytoplasmique et membranaire du rNK1 dans les neurones 5-HT, sans aucun changement dans les neurones non 5-HT. Ces traitements ont aussi augmenté l’expression du gène rNK1 dans le NRD. Enfin, nous avons mesuré une hausse de la densité membranaire du rNK1 dans les neurones 5-HT, sans hausse de densité cytoplasmique, par suite d’une lésion bilatérale de l’habenula.
Ces résultats confortent l’hypothèse d’une activation et d’une internalisation soutenues des rNK1 par la SP dans les neurones 5-HT du NRD caudal. Ils suggèrent aussi que le trafic des rNK1 dans les neurones 5-HT du NRD représente un mécanisme cellulaire en contrôle de l’activation du système 5-HT par les afférences SP en provenance de l’habenula. / We have studied in detail the relationships between substance P (SP) and serotonin (5-hydroxytryptamine, 5-HT) neurotransmission systems in the dorsal raphe nucleus (DRN) of rodents, in order to further our understanding of their interaction during mood regulation.
The DRN receives a SP innervation arising from the habenula and, in human, it is known that blockade of the neurokinin-1 receptor (NK1r) of SP by antagonists may have antidepressant effects. In rodents, treatment with NK1r antagonists is known to increase the firing of DRN 5-HT neurons and to induce a desensitization of their 5-HT1A autoreceptors, suggesting local interactions between the SP and 5-HT systems.
In a first step, we were able to demonstrate by means of light, confocal, and electron microscopic immunocytochemistry, including double immunolabelings of NK1r and of the biosynthetic enzyme of 5-HT, tryptophane hydroxylase, the presence of NK1r in a subpopulation of 5-HT neurons in the caudal DRN of rat and mouse. After the dual immunolabelings for electron microscopy, we also found that NK1r was mostly cytoplasmic in 5-HT neurons while predominating on the plasma membrane of TPH negative (non 5-HT) neurons. Subsequently, in additionnal double labeling experiments, we were able to identify most if not all non 5-HT dendrites bearing membranous NK1r as GABAergic.
In a second step, we combined the immunolabeling of SP with that of NK1r, in order to examine the relationships between SP axon terminals (varicosities *) and the two categories of DRN neurons (5-HT: cytoplasmic NK1r; non 5-HT: membranous NK1r). After single SP labeling, we could estimate the frequency with which SP terminals made synapse at 41%, at least. In the material doubly labeled for SP and NK1r, the SP terminals were often found in close contact or in the immediate proximity of dendrites endowed with cytoplasmic receptor, but never near non 5-HT dendrites bearing membrane bound receptors. To test the hypothesis of a sustained internalization of NK1r in 5-HT neurons, we then tested the effects of RP67580, a selective NK1r antagonist, on the subcellular localization of the receptor. One hour after administration of a single dose, the NK1r distribution was unchanged in both types of dendrites (5-HT and non 5-HT). However, after administration for 7 (subchronic) or 21 (chronic) days, the cytoplasmic and the membrane densities of NK1r were significantly increased in 5-HT dendrites, without any change in non 5-HT dendrites. These treatments also increased NK1r gene expression in the caudal DRN. Lastly, a significant increase in the membrane density of NK1r was measured in the 5-HT neurons, without any increase of the cytoplamic density, following bilateral electrolytic lesioning of the habenula. These results strenghtened the hypothesis of a sustained activation and internalization of NK1r by SP in 5-HT neurons of the caudal DRN. They also suggested that trafficking of NK1r in these cells might represent a cellular mechanism in control of the activation of the 5-HT system by SP afferents from the habebula.
|
58 |
Estudo do envolvimento do sistema serotoninérgico do núcleo dorsal da rafe na elaboração do comportamento de defesa e da antinocicepção induzida pelo medo inato evocados por estimulação química dos corpos quadrigêmeos / Study of the involvement of dorsal raphe nucleus serotonergic system in the elaboration of defensive behaviour and fear-induced antinociception elicited by corpora quadrigemina chemical stimulationSoares Junior, Raimundo da Silva 26 February 2019 (has links)
Há estudos que mostraram que o ácido N-metil-D-aspártico (NMDA), microinjetado nas estruturas do teto mesencefálico (corpos quadrigêmeos) de ratos evoca comportamentos defensivos do tipo pânico que podem ser seguidos por uma resposta antinociceptiva. Tem sido sugerido que respostas defensivas relacionadas ao medo organizadas por neurônios do tronco cerebral podem ser moduladas por projeções ascendentes mediadas pelo neurotransmissor 5-hidroxitriptamina (5-HT) do núcleo dorsal da rafe (NDR), e fenômenos antinociceptivos induzidos pelo medo inato podem ser organizados por vias serotoninérgicas descendentes também originadas no NDR. Os neurônios do NDR que originam tais conexões, por sua vez, podem ser moduladas por monoaminas que recrutam receptores 5-HT2A localizados no NDR. Não obstante, háuma escassez de estudos mostrando o papel dos receptores 5-HT2A do NDR na modulação do comportamento do tipo pânico e da antinocicepção induzida pelo medo inato organizados nos colículos superiores e inferiores. O objetivo deste estudo foi investigar a participação dos receptores 5-HT2A do NDR na modulação do comportamento de defesa organizado pelos corpos quadrigêmeos e da antinocicepção induzida pelo medo evocados por microinjeções de NMDA nos corpos quadrigêmeos. No experimento I, os animais receberam microinjeção de veículo (NaCl 0,9% / 0,2?L) ou 6, 9 e 12 nmol NMDA no CI. No experimento II, foi realizado o pré-tratamento do NDR com microinjeções de veículo ou o antagonista seletivo do receptor 5HT2A (R-96544) nas concentrações de 5, 10 e 15 nM. Dez minutos depois, o NMDA na dose mais efetiva (12 nmol) foi injetado no CI. Em ambos os experimentos, as respostas defensivas foram analisadas quantitativamente durante 10 min e, em seguida, as latências de retirada de cauda foram medidas a intervalos de 10 min durante 70 min. No experimento III, os animais receberam microinjeção de salina fisiológica ou NMDA (6, 9 e 12 nmol) nas cpSC. No experimento IV, a dose mais efetiva de NMDA (12 nmol) ou veículo foi precedida por microinjeções de veículo ou antagonista seletivo do receptor 5HT2A (R- 96544) em diferentes concentrações, 0.5, 5 e 10 nM. Ambos os efeitos pró-eversivos e antinociceptivos provocados pelas injecções intra-cpCS de NMDA foram atenuados pelo pré-tratamento do NDR com R-96544. No experimento V, a análise morfológica mostrou que os receptores 5-HT2A estão presentes nos interneurônios GABAérgicos do NDR. Em conjunto, esses achados sugerem que o bloqueio dos receptores 5-HT2A no NDR é capaz de atenuar tanto o comportamento defensivo do tipo pânico quanto a antinocicepção induzida pelo medo organizada pelos corpos quadrigêmeos. / There are studies that suggest that N-methyl-D-aspartic acid (NMDA) microinjected into the midbrain tectum structures, such corpora quadrigemina, of rats evokes panic-like defensive behaviours that can be followed by an antinociceptive response. It has been suggested that fear-related defensive responses organised by brainstem neurons can be modulated by ascending projections mediated by the neurotransmitter 5-hydroxytryptamine (5-HT) of the dorsal raphe nucleus (DRN), and phenomena of innate fear-induced antinociception can be organised by descending serotonergic pathways also originating from the DRN. The DRN neurons that give rise to such connections, in turn, can be moduled by monoamines that recruit 5-HT2A receptors located in the DRN. Nevertheless, there is a shortage of studies showing the role of DRN 5-HT2A receptors in the modulation of panic-like behaviour and innate fearinduced antinociception organised by superior and inferior colliculi. The purpose of this study was to investigate the participation of DRN 5-HT2A receptors in the modulation of panic-like behaviour and antinociception evoked by corpora quadrigemina injections of NMDA. In experiment I, the animals received microinjection of vehicle (0.9%NaCl/0.2?L) or 6, 9 and 12 nmol NMDA into the IC. In experiment II, it was performed the pretreatment of DRN with microinjections of vehicle or the 5HT2A receptor selective antagonist (R-96544) in a concentration of 5, 10 and 15 nM. Ten minutes later, NMDA at the most effective dose (12nmol) was injected in the IC. In both experiments, the defensive responses were quantitatively analysed for 10 min and then the tail-flick withdrawal latencies were measured at 10 min-intervals for 70 min. In experiment III, the animals received microinjection of physiological saline or NMDA (6, 9 and 12 nmol) into the deep layers of SC (dlSC). In experiment IV, the most effective dose of NMDA (12 nmol) or vehicle was preceded by microinjections of vehicle or 5HT2A receptor selective antagonist (R-96544) at different concentrations (0.5, 5, and 10 nM). Both proaversive and antinociceptive effects elicited by intra-dlSC injections of NMDA were attenuated by the pretreatment of the DRN with R-96544. In experiment V, the morphological analysis showed that 5-HT2A receptors are present in GABAergic interneurons in the DRN. Taken together, these findings suggest that the blockade of DRN 5-HT2A receptors decreased both panic attack-like defensive behaviour and fear- induced antinociception organised by the corpora quadrigemina neurons.
|
59 |
Origem da inervação dopaminérgica da divisão central da amígdala expandida e da concha do núcleo Acumbens no rato. / Origin of dopaminergic fibers to the central extended amygdala and nucleus accumbens shell in the rat.Hasue, Renata Hydee 23 January 2001 (has links)
A amígdala expandida central (EAc) inclui os núcleos central da amígdala (CeA), intersticial lateral da estria terminal (BSTl), intersticial do ramo posterior da comissura anterior (IPAC) e amígdala expandida sublenticular (SLEA). A EAc e a concha do acumbens possuem densa inervação dopaminérgica, implicada em processos motivacionais, e cuja origem foi estudada com a técnica de dupla marcação celular, combinando-se imunofluorescência para o traçador retrógrado Fluoro-Gold e para a tirosina hidroxilase. Nossos resultados indicam que a inervação dopaminérgica do CeA e BSTl é semelhante, se originando em igual proporção da área tegmental ventral (A10) e do núcleo dorsal da rafe/substância cinzenta periaquedutal (A10dc). A inervação dopaminérgica da SLEA, IPAC e concha do acumbens se origina principalmente do grupo A10. Com um anticorpo específico para dopamina vimos que parte da projeção do A10dc para o CeA é de fato dopaminérgica. Os grupos dopaminérgicos diencefálicos não inervam a EAc e a concha do acumbens. / The central extended amygdala (EAc) includes the central amygdaloid nucleus (CeA), lateral bed nucleus of the stria terminalis (BSTl), interstitial nucleus of the posterior limb of the anterior commissure (IPAC) and sublenticular extended amygdala (SLEA). The dopaminergic innervation of the EAc and nucleus accumbens shell is functionally related to motivational processes. Its origin was studied by combining immunofluorescence to tyrosine hydroxylase and Fluoro-Gold, used as retrograde tracer. Our results show that dopaminergic fibers to the CeA and BSTl derive in equal proportion from neurons in ventral tegmental area (A10) and in dorsal raphe nucleus/periaqueductal gray (A10dc). Dopaminergic inputs to SLEA, IPAC and accumbens shell arise mainly from A10 neurons. Using a dopamine antibody, we confirmed that A10dc projections to CeA are in part dopaminergic. Futhermore, the present data indicate that the diencephalic dopaminergic groups do not project to EAc and accumbens shell.
|
60 |
Substance P, récepteurs NK1 et neurones à sérotonine : relations anatomiques et fonctionnelles dans le noyau raphe dorsalisBaptiste, Lacoste 06 1900 (has links)
Nous avons étudié les relations anatomiques entre les systèmes de neurotransmission à substance P (SP) et à sérotonine (5-hydroxytryptamine, 5-HT) dans le noyau du raphé dorsal (NRD) du rongeur, afin de mieux comprendre les interactions entre ces systèmes durant la régulation de l’humeur.
Le NRD reçoit une innervation SP provenant de l’habenula, et le blocage pharmacologique des récepteurs neurokinine-1 (rNK1) de la SP aurait des effets antidépresseurs. Chez le rongeur, le traitement par les antagonistes des rNK1 s’accompagne d’une désensibilisation des autorécepteurs 5-HT1A de la 5-HT et d’une hausse de l’activité des neurones 5-HT dans le NRD, suggérant des interactions locales entre ces deux systèmes.
Dans un premier temps, nous avons démontré par doubles marquages immunocytochimiques en microscopies optique, confocale et électronique, la présence du rNK1 dans une sous-population de neurones 5-HT du NRD caudal. Lors de l’analyse en microscopie électronique, nous avons pu constater que les rNK1 étaient principalement cytoplasmiques dans les neurones 5-HT et membranaires sur les neurones non 5-HT du noyau. Grâce à d’autres doubles marquages, nous avons aussi pu identifier les neurones non-5-HT porteurs de rNK1 comme étant GABAergiques.
Nous avons ensuite combiné l’immunomarquage de la SP avec celui du rNK1, dans le but d’examiner les relations entre les terminaisons (varicosités *) axonales SP et les neurones 5-HT (pourvus de rNK1 cytoplasmiques du NRD caudal. En simple marquage de la SP, nous avons pu estimer à 41% la fréquence avec laquelle les terminaisons SP font synapse. Dans le matériel doublement marqué pour la SP et son récepteur, les terminaisons SP ont été fréquemment retrouvées en contact direct ou à proximité des dendrites munies de rNK1 cytoplasmiques, mais toujours éloignées des dendrites à rNK1 membranaires. Pour tester l’hypothèse d’une internalisation soutenue des rNK1 par la SP dans les neurones 5-HT, nous avons ensuite examiné la localisation subcellulaire du récepteur chez le rat traité avec un antagoniste du rNK1, le RP67580. La densité du marquage des rNK1 a été mesurée dans le cytoplasme et sur la membrane des deux types de dendrites (5-HT: rNK1 cytoplasmiques; non 5-HT: rNK1 membranaires). Une heure après une injection unique de l’antagoniste, la distribution du rNK1 est apparue inchangée dans les deux types de neurones (5-HT et non 5-HT). Par contre, après un traitement quotidien de 7 ou 21 jours avec l’antagoniste, nous avons mesuré une augmentation significative des densités cytoplasmique et membranaire du rNK1 dans les neurones 5-HT, sans aucun changement dans les neurones non 5-HT. Ces traitements ont aussi augmenté l’expression du gène rNK1 dans le NRD. Enfin, nous avons mesuré une hausse de la densité membranaire du rNK1 dans les neurones 5-HT, sans hausse de densité cytoplasmique, par suite d’une lésion bilatérale de l’habenula.
Ces résultats confortent l’hypothèse d’une activation et d’une internalisation soutenues des rNK1 par la SP dans les neurones 5-HT du NRD caudal. Ils suggèrent aussi que le trafic des rNK1 dans les neurones 5-HT du NRD représente un mécanisme cellulaire en contrôle de l’activation du système 5-HT par les afférences SP en provenance de l’habenula. / We have studied in detail the relationships between substance P (SP) and serotonin (5-hydroxytryptamine, 5-HT) neurotransmission systems in the dorsal raphe nucleus (DRN) of rodents, in order to further our understanding of their interaction during mood regulation.
The DRN receives a SP innervation arising from the habenula and, in human, it is known that blockade of the neurokinin-1 receptor (NK1r) of SP by antagonists may have antidepressant effects. In rodents, treatment with NK1r antagonists is known to increase the firing of DRN 5-HT neurons and to induce a desensitization of their 5-HT1A autoreceptors, suggesting local interactions between the SP and 5-HT systems.
In a first step, we were able to demonstrate by means of light, confocal, and electron microscopic immunocytochemistry, including double immunolabelings of NK1r and of the biosynthetic enzyme of 5-HT, tryptophane hydroxylase, the presence of NK1r in a subpopulation of 5-HT neurons in the caudal DRN of rat and mouse. After the dual immunolabelings for electron microscopy, we also found that NK1r was mostly cytoplasmic in 5-HT neurons while predominating on the plasma membrane of TPH negative (non 5-HT) neurons. Subsequently, in additionnal double labeling experiments, we were able to identify most if not all non 5-HT dendrites bearing membranous NK1r as GABAergic.
In a second step, we combined the immunolabeling of SP with that of NK1r, in order to examine the relationships between SP axon terminals (varicosities *) and the two categories of DRN neurons (5-HT: cytoplasmic NK1r; non 5-HT: membranous NK1r). After single SP labeling, we could estimate the frequency with which SP terminals made synapse at 41%, at least. In the material doubly labeled for SP and NK1r, the SP terminals were often found in close contact or in the immediate proximity of dendrites endowed with cytoplasmic receptor, but never near non 5-HT dendrites bearing membrane bound receptors. To test the hypothesis of a sustained internalization of NK1r in 5-HT neurons, we then tested the effects of RP67580, a selective NK1r antagonist, on the subcellular localization of the receptor. One hour after administration of a single dose, the NK1r distribution was unchanged in both types of dendrites (5-HT and non 5-HT). However, after administration for 7 (subchronic) or 21 (chronic) days, the cytoplasmic and the membrane densities of NK1r were significantly increased in 5-HT dendrites, without any change in non 5-HT dendrites. These treatments also increased NK1r gene expression in the caudal DRN. Lastly, a significant increase in the membrane density of NK1r was measured in the 5-HT neurons, without any increase of the cytoplamic density, following bilateral electrolytic lesioning of the habenula. These results strenghtened the hypothesis of a sustained activation and internalization of NK1r by SP in 5-HT neurons of the caudal DRN. They also suggested that trafficking of NK1r in these cells might represent a cellular mechanism in control of the activation of the 5-HT system by SP afferents from the habebula.
|
Page generated in 0.0363 seconds